Item

Heuckmann,  Johannes M.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Hölzel,  Michael
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States d Chemical Genomics Center, Max Planck Society, Dortmund, Germany e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;

Sos,  Martin L.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Heynck,  Stefanie
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Balke-Want,  Hyatt
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Koker,  Mirjam
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Peifer,  Martin
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Weiss,  Jonathan
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Lovly,  Christine M.
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States d Chemical Genomics Center, Max Planck Society, Dortmund, Germany e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;

Grütter,  Christian
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States d Chemical Genomics Center, Max Planck Society, Dortmund, Germany e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;

Rauh,  Daniel
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States d Chemical Genomics Center, Max Planck Society, Dortmund, Germany e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;

Pao,  William
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States d Chemical Genomics Center, Max Planck Society, Dortmund, Germany e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;

Thomas,  Roman K.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;